Harman Patil

AVN 101

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
ChemSpider  24643855
Formula  C21H24N2
3D model (Jmol)  Interactive image
ChEMBL  CHEMBL592752
Molar mass  304.44 gĀ·mol
AVN-101

AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.

References

AVN-101 Wikipedia


Similar Topics
The Death of the Incredible Hulk
Jihad Ballout
Bob Murray (Australian footballer)
Topics